Last edition
News about "cardiovascular risk "
NIH-Supported Study Links Sleep ECG Data to Future Cardiac Risk
NIH-supported study found that combining sleep-stage information with single-lead ECG recordings could help identify people at higher risk of future cardiovascular outcomes.
Cardiovascular Risk | 12/10/2026 | By News Bureau
Novartis Reports Phase 3 Results for Pelacarsen in Cardiovascular Disease
Novartis reports phase 3 Lp(a)HORIZON topline results for pelacarsen, an investigational ASO targeting Lp(a) production in patients with cardiovascular disease (CVD).
Cardiovascular Risk | 05/09/2026 | By News Bureau | 148
Zydus Secures Final Approval from USFDA for Niacin Extended-Release Tablets
Zydus Lifesciences has received final USFDA approval to manufacture Niacin Extended-Release Tablets in 500 mg, 750 mg, and 1,000 mg dosage, targeting cholesterol management and cardiovascular risk reduction.
Cardiovascular Risk | 30/04/2025 | By Abha | 608
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy